These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 1806766

  • 1. Hybrid molecules: insights into plasminogen activator function.
    Runge MS, Bode C, Haber E, Quertermous T.
    Mol Biol Med; 1991 Apr; 8(2):245-55. PubMed ID: 1806766
    [Abstract] [Full Text] [Related]

  • 2. Bispecific monoclonal antibodies produced by somatic cell fusion increase the potency of tissue plasminogen activator.
    Branscomb EE, Runge MS, Savard CE, Adams KM, Matsueda GR, Haber E.
    Thromb Haemost; 1990 Oct 22; 64(2):260-6. PubMed ID: 2125375
    [Abstract] [Full Text] [Related]

  • 3. Enhancement of clot lysis in vitro and in vivo with a bispecific monoclonal antibody directed against human fibrin and against urokinase-type plasminogen activator.
    Kurokawa T, Iwasa S, Kakinuma A, Stassen JM, Lijnen HR, Collen D.
    Thromb Haemost; 1991 Dec 02; 66(6):684-93. PubMed ID: 1796414
    [Abstract] [Full Text] [Related]

  • 4. The effector roles of kringle 1 and kringle 2 in the enzymatic properties of recombinant tissue-type plasminogen activator as revealed by generation of recombinant molecules containing each kringle linked to the protease domain.
    Rydzewski A, Castellino FJ.
    Arch Biochem Biophys; 1993 Jan 02; 300(1):472-82. PubMed ID: 8424682
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The construction and expression of chimeric urokinase-type plasminogen activator genes containing kringle domains of human plasminogen.
    Boutaud A, Castellino FJ.
    Arch Biochem Biophys; 1993 Jun 02; 303(2):222-30. PubMed ID: 8512311
    [Abstract] [Full Text] [Related]

  • 7. Conjugation to an antifibrin monoclonal antibody enhances the fibrinolytic potency of tissue plasminogen activator in vitro.
    Runge MS, Bode C, Matsueda GR, Haber E.
    Biochemistry; 1988 Feb 23; 27(4):1153-7. PubMed ID: 3130094
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Enhanced thrombolysis in plasma and in vivo by single-chain urokinase-type plasminogen activator (scuPA) conjugated to an antifibrin antibody.
    Bode C, Runge M, Eberle T, Freitag M, Kübler W, Haber E.
    Trans Assoc Am Physicians; 1989 Feb 23; 102():7-12. PubMed ID: 2517856
    [No Abstract] [Full Text] [Related]

  • 13. The tissue plasminogen activator finger domain confers fibrin-dependent enhancement of catalytic activity to single-chain urokinase-type plasminogen activator.
    Lubin IM, Caban R, Runge MS.
    J Biol Chem; 1993 Mar 15; 268(8):5550-6. PubMed ID: 8449917
    [Abstract] [Full Text] [Related]

  • 14. Enhanced thrombolytic and antithrombotic potency of a fibrin-targeted plasminogen activator in baboons.
    Runge MS, Harker LA, Bode C, Ruef J, Kelly AB, Marzec UM, Allen E, Caban R, Shaw SY, Haber E, Hanson SR.
    Circulation; 1996 Sep 15; 94(6):1412-22. PubMed ID: 8823001
    [Abstract] [Full Text] [Related]

  • 15. Characterization of a recombinant chimeric plasminogen activator composed of a fibrin fragment-D-dimer-specific humanized monoclonal antibody and a truncated single-chain urokinase.
    Vandamme AM, Dewerchin M, Lijnen HR, Bernar H, Bulens F, Nelles L, Collen D.
    Eur J Biochem; 1992 Apr 01; 205(1):139-46. PubMed ID: 1313361
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Functional effects of kringle 2 glycosylation in a hybrid plasminogen activator.
    Asselbergs FA, Bürgi R, van Oostrum J.
    Blood Coagul Fibrinolysis; 1993 Feb 01; 4(1):27-33. PubMed ID: 8384498
    [Abstract] [Full Text] [Related]

  • 19. Fibrin-specificity of a plasminogen activator affects the efficiency of fibrinolysis and responsiveness to ultrasound: comparison of nine plasminogen activators in vitro.
    Sakharov DV, Barrertt-Bergshoeff M, Hekkenberg RT, Rijken DC.
    Thromb Haemost; 1999 Apr 01; 81(4):605-12. PubMed ID: 10235448
    [Abstract] [Full Text] [Related]

  • 20. Structure and function of human tissue-type plasminogen activator (t-PA).
    van Zonneveld AJ, Veerman H, MacDonald ME, van Mourik JA, Pannekoek H.
    J Cell Biochem; 1986 Apr 01; 32(3):169-78. PubMed ID: 3097031
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.